Medical News

RSS

UB scientists discover promising new drug target for Alzheimer's

A tiny piece of a critical receptor that fuels the brain and without which sentient beings cannot live has been discovered by University at Buffalo scientists as a promising new drug target for Alzheimer's and other neurodegenerative diseases.

12 Oct 2011

Elsevier launches new browser for readers to explore protein interactions

Elsevier, a world-leading provider of scientific, medical and technical products and services, introduces the Protein Interaction Browser, a new application available on SciVerse ScienceDirect.

12 Oct 2011

Furiex announces publications and presentations about antibacterial drug JNJ-Q2

Furiex Pharmaceuticals, Inc. today announced recent and upcoming publications and presentations about the novel investigational antibacterial drug JNJ-Q2.

12 Oct 2011

UPC develops active knee-ankle orthosis to assist gait in people with incomplete SCI

A team from the Department of Mechanical Engineering and the Biomedical Engineering Research Centre (CREB) of the Universitat Politècnica de Catalunya. BarcelonaTech (UPC) has developed an active knee-ankle orthosis to assist gait in people with incomplete spinal cord injury. The project is being carried out in collaboration with the University of A Coruña and the University of Extremadura.

12 Oct 2011

Preliminary analysis suggests $258M HIV/AIDS prevention program in India may have prevented some 100,000 infections

A $258 million HIV/AIDS prevention program in six Indian states may have prevented an estimated 100,000 infections from 2003 to 2008, researchers from the Public Health Foundation of India and the University of Washington suggest in a study published in the Lancet on Tuesday, the Associated Press/Washington Post reports.

12 Oct 2011

UCSF, Anacor to discover and optimize novel oxaboroles as antimalarial drugs

Anacor Pharmaceuticals announced today that the University of California San Francisco (UCSF) has been awarded $718,136 in funding from the National Institutes of Health (NIH) to discover and optimize novel oxaboroles as antimalarial drugs in collaboration with Anacor Pharmaceuticals. The NIH grant provides support for the period beginning September 30, 2011 and ending September 29, 2012.

12 Oct 2011

COPAXONE reduces loss of brain volume in patients with RRMS

Results from a five-year study of treatment-naïve patients with relapsing-remitting multiple sclerosis (RRMS) demonstrated that patients treated with COPAXONE (glatiramer acetate injection) showed significant reduced loss of brain volume compared to patients treated with other disease modifying therapies.

12 Oct 2011

High street connectivity has opposite effect on children's physical activity

High intersection density and well-connected streets in towns and cities may discourage children from being active and exercising outdoors, according to a Queen's University study.

12 Oct 2011

K.S.R. Educational Institutions of India, MU sign five-year academic agreement

University of Missouri officials announced today a five-year agreement with K.S.R. Educational Institutions of India that will promote advanced research and training in nanomedicine and nanotechnology.

12 Oct 2011

Viewpoints: The value of testing for prostate cancer; rewards for transplant donors; Calif.'s medical marijuana problem

For men older than 50, a simple blood test to screen for prostate cancer is as much a part of annual physicals as weigh-ins and stethoscopes. The PSA test is painless, inexpensive and the only way to detect the disease - the most common male cancer - before symptoms turn up.

12 Oct 2011

New robust technique holds promise for identifying trace mutant DNA sequences

Molecular DNA testing methods offer clinicians powerful tools that serve to confirm or identify disease diagnoses. High sensitivity and high specificity, however, are frequently a challenge to achieve with these methods. In a study scheduled for publication in the November issue of The Journal of Molecular Diagnostics, researchers describe a new, robust technique that holds promise for identifying trace mutant DNA sequences in an overwhelming population of unmutated DNA.

12 Oct 2011

PROLOR receives U.S. patent allowance for CTP-modified interferons

PROLOR Biotech, Inc. today announced that it received a notice of allowance from the U.S. Patent and Trademark Office (PTO) for a patent application covering PROLOR's CTP-modified interferons.

12 Oct 2011

AzTE, Roche sign license agreement to develop revolutionary DNA sequencing system

Roche and Arizona Technology Enterprises (AzTE) announced today an agreement to license several technologies developed by Dr. Stuart Lindsay at the Biodesign Institute- at Arizona State University and Dr. Colin Nuckolls of the Columbia University Nanoscience Center for the development of a revolutionary DNA sequencing system.

12 Oct 2011

Phyllodes tumors more prevalent among Hispanic women

According to a study published in the October issue of the Journal of the American College of Surgeons, phyllodes tumors - rare breast malignancies accounting for 0.5 to one percent of all breast tumors - tend to be more prevalent in Hispanic patients.

12 Oct 2011

CHOP, Albert Einstein College of Medicine to study genetics of conotruncal defects

The Eunice Kennedy Shriver National Institute of Child Health & Human Development, part of the National Institutes of Health, has awarded researchers at Albert Einstein College of Medicine of Yeshiva University and collaborators at the Children's Hospital of Philadelphia (CHOP) a five-year, $6.7 million grant to study the genetics of both rare and common congenital heart abnormalities known as conotruncal defects.

12 Oct 2011

AOA launches new easy-to-use Web site about contact lens safety

The American Optometric Association (AOA) launched www.ContactLensSafety.org, a new, easy-to-use Web site to help answer consumer questions about contact lens safety.

12 Oct 2011

FDA approves NDA for Edgemont's Fluoxetine 60 mg tablet

Edgemont Pharmaceuticals, LLC, a neuroscience focused company, today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Fluoxetine Tablets 60 mg.

12 Oct 2011

Boston Therapeutics initiates PAZ320 clinical trial in Type 2 Diabetes

Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, announced today the initiation of its first clinical trial to evaluate the Safety and Efficacy of PAZ320 when added to oral agents or Insulin regimen in Patients with Type 2 Diabetes Mellitus.

12 Oct 2011

Russian Foreign Minister says country's HIV/AIDS problem is being 'aggravated' by U.S., NATO refusal to eradicate poppy crops in Afghanistan

Speaking on Monday at a conference on communicable diseases in the eastern Europe and Central Asia region, where AIDS is a growing problem, Russian Foreign Minister Sergei Lavrov made Russia's case for poppy crop eradication by U.S. and NATO forces in Afghanistan asserting that the West "is aggravating the HIV/AIDS problem in Russia and the West by refusing to use its forces to destroy opium crops in Afghanistan," Reuters reports.

12 Oct 2011

Over 6,000 Australians joined ‘Weigh it Up Australia’

Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up’s new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.

11 Oct 2011